Article
KRAS gene mutations - prognostic factor in colorectal cancer?
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie - 1 Jan 2015
Dobre Maria, Dinu Daniela Elena, Panaitescu Eugenia, Bîrlă Rodica Daniela, Iosif Cristina Ileana, Boeriu Marius, Constantinoiu Silviu, Ivan Roxana Nicoleta, Ardeleanu Carmen Maria, Costache Marieta
Abstract excerpt
The colorectal cancer (CRC) modern therapy is using adjuvant and neoadjuvant companion therapeutic agents, part of them having an anti-angiogenic action. Their benefic effect can be annulated by some gene mutations, which are interfering in signal transduction pathways. One of the more frequent activating mutations is occurring in the KRAS gene. We assessed the KRAS mutations by two molecular methods, in a group...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
